Pharmacovigilance Evaluation Of Refacto Af (Registered) In Germany And Austria
Pharmacovigilance Evaluation Of Refacto Af (Registered) In Germany And Austria
The purpose of this observational study is to describe the incidence of adverse events among patients treated with Refacto AF in usual health care settings in Germany and Austria.
Non-interventional study: subjects to be selected according to the usual clinical practice of their physician
Inclusion Criteria:
Exclusion Criteria:
Düsseldorf, 40225, Germany
Frankfurt A. M., 60596, Germany